Synthesis, Characterization, Bioactivity Evaluation, and POM/DFT/Docking Analysis of Novel Thiazolidine Derivatives as Potent Anticancer and Antifungal Agents

被引:0
|
作者
Majed, Ahmed A. [1 ]
Abdalzahra, Qeaser R. [2 ]
Al-Hujaj, Hamsa H. [3 ]
Abid, Dawood S. [1 ]
Alomari, Abdulaziz A. [4 ]
Abdellah, Islam M. [5 ,6 ]
Elhenawy, Ahmed A. [7 ]
机构
[1] Basrah Univ, Coll Educ Pure Sci, Dept Chem, Basrah, Iraq
[2] Basrah Univ Oil & Gas, Coll Oil & Gas Engn, Dept Oil & Gas Engn, Basrah, Iraq
[3] Univ Basrah, Dept Pharmaceut Chem, Collage Pharm, Basrah, Iraq
[4] Al Baha Univ, Fac Sci, Chem Dept, Al Baha, Saudi Arabia
[5] North Carolina State Univ, Polymer & Color Chem Program, Raleigh, NC 27606 USA
[6] Aswan Univ, Fac Sci, Dept Chem, Aswan 81528, Egypt
[7] Al Azhar Univ, Fac Sci, Chem Dept, Cairo, Egypt
来源
CHEMISTRYSELECT | 2024年 / 9卷 / 40期
关键词
Synthesis; Thiazolidine; Bioactivity; POM/DFT/TDFT; Docking; DOCKING;
D O I
10.1002/slct.202403761
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of 2,2 '-(1,4-phenylene)bis(N-substituted phenylthiazolidine-4-amide) derivatives, denoted as (A3-9), were synthesized, and characterized for their potential applications against prostate cancer cells (PC3), and Candida albicans fungi. These compounds incorporate various substituents on the phenyl ring such as 4-NO2, 3-NO2, 4-COCH3, 4-H, 4-OCH3, 4-OCH2CH3, and 4-Cl. The chemical structures of these derivatives were confirmed by NMR, FTIR, and mass spectroscopy. Biological assays, utilizing the MTT assay for prostate cancer cells (PC3) and the disk diffusion assay for Candida albicans fungi, were conducted to evaluate the bioactivity of these compounds. The results revealed promising cytotoxic and antifungal activities. Specifically, compounds A3 (IC50=69.74 +/- 0.96), A4 (IC50=63.64 +/- 0.950), and A9 (IC50=57.14 +/- 0.88 mu g/mL) exhibited notable potency against PC3 cells, while A7 and A8 exhibited considerable antifungal efficacy against Candida albicans with MIC of 312 mu g/mL. Moreover, density functional theory (DFT) simulations were used to study electronic properties and reactivity descriptors such as energy gap (Eg), ionization potential (IP), electron affinity (EA), chemical potential (mu), chemical hardness (eta), global softness (sigma), electronegativity (chi), and electrophilicity (omega) to gain a better understanding of the Structure-Activity Relationship (SAR). Molecular docking analysis against DNA Gyrase and EGFR tyrosine kinase enzymes revealed strong binding interactions of the investigated molecules within their active sites, making them valuable candidates for further development as therapeutic agents against prostate cancer and fungal infections. POM analysis indicates the presence of two antifungal pharmacophore sites (O1 delta-, O2 delta-) and (O3 delta-, O4 delta-), as well as two antitumor pharmacophore sites (O1 delta-, NH1 delta+) and (O4 delta-, NH2 delta+).
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Green synthesis and biological evaluation of novel 5-fluorouracil derivatives as potent anticancer agents
    Jubeen, Farhat
    Liaqat, Aisha
    Sultan, Misbah
    Iqbal, Sania Zafar
    Sajid, Imran
    Sher, Farooq
    SAUDI PHARMACEUTICAL JOURNAL, 2019, 27 (08) : 1164 - 1173
  • [42] SYNTHESIS AND EVALUATION OF NOVEL THIOSEMICARBAZONE DERIVATIVES AS ANTICANCER AGENTS
    Gokhale, Niharika
    Jain, Sanjay
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2015, 6 (04): : 1792 - 1804
  • [43] Synthesis and evaluation of a novel class of ethacrynic acid derivatives containing triazoles as potent anticancer agents
    El Abbouchi, Abdelmoula
    El Brahmi, Nabil
    Hiebel, Marie -Aude
    Bignon, Jerome
    Guillaumet, Gerald
    Suzenet, Franck
    El Kazzouli, Said
    BIOORGANIC CHEMISTRY, 2021, 115
  • [44] Synthesis, Molecular Modeling, and Biological Evaluation of Novel Chiral Thiosemicarbazone Derivatives as Potent Anticancer Agents
    Tasdemir, Demet
    Karakucuk-Iyidogan, Aysegul
    Ulasli, Mustafa
    Taskin-Tok, Tugba
    Oruc-Emre, Emine Elcin
    Bayram, Hasan
    CHIRALITY, 2015, 27 (02) : 177 - 188
  • [45] Synthesis and Evaluation of Chalcone Derivatives as Novel Anticancer Agents
    Sheng, Qiwei
    Zhao, Wanqiu
    Zeng, Ming
    Xie, Zhongpao
    Xia, Yaping
    Cui, Dongmei
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2019, 39 (03) : 703 - 708
  • [46] Design, synthesis and mechanism of novel shikonin derivatives as potent anticancer agents
    Baloch, Shahla Karim
    Ma, Lin
    Wang, Xue-Liang
    Shi, Jing
    Zhu, Yu
    Wu, Feng-Yao
    Pang, Yan-Jun
    Lu, Gui-Hua
    Qi, Jin-Liang
    Wang, Xiao-Ming
    Gu, Hong-Wei
    Yang, Yong-Hua
    RSC ADVANCES, 2015, 5 (40) : 31759 - 31767
  • [47] Synthesis, characterization, POM analysis and antifungal activity of novel heterocyclic chalcone derivatives containing acylated pyrazole
    Helmi Mohammed Al-Maqtari
    Joazaizulfazli Jamalis
    Taibi Ben Hadda
    Murugesan Sankaranarayanan
    Subhash Chander
    Noor Aisyah Ahmad
    Hasnah Mohd Sirat
    Ismail I. Althagafi
    Yahia Naseer Mabkhot
    Research on Chemical Intermediates, 2017, 43 : 1893 - 1907
  • [48] Synthesis, characterization, POM analysis and antifungal activity of novel heterocyclic chalcone derivatives containing acylated pyrazole
    Al-Maqtari, Helmi Mohammed
    Jamalis, Joazaizulfazli
    Ben Hadda, Taibi
    Sankaranarayanan, Murugesan
    Chander, Subhash
    Ahmad, Noor Aisyah
    Sirat, Hasnah Mohd
    Althagafi, Ismail I.
    Mabkhot, Yahia Naseer
    RESEARCH ON CHEMICAL INTERMEDIATES, 2017, 43 (03) : 1893 - 1907
  • [49] Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors
    Ebrahim Saeedian Moghadam
    Abdullah Mohammed Al-Sadi
    Meysam Talebi
    Massoud Amanlou
    Mohsen Amini
    Raid Abdel-Jalil
    DARU Journal of Pharmaceutical Sciences, 2022, 30 : 29 - 37
  • [50] Novel benzimidazole derivatives; synthesis, bioactivity and molecular docking study as potent urease inhibitors
    Moghadam, Ebrahim Saeedian
    Al-Sadi, Abdullah Mohammed
    Talebi, Meysam
    Amanlou, Massoud
    Amini, Mohsen
    Abdel-Jalil, Raid
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 30 (01) : 29 - 37